Clinical Trial Update: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Interleukin-11 plus filgrastim as a pre-transplant regimen for patients undergoing peripheral stem cell transplantation. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hodgkin Lymphoma
• Kidney Cancer
• Neuroblastoma
• Non-hodgkin Lymphoma
• Ovarian Cancer
• Sarcoma
• Testicular Germ Cell Tumor

Drugs mentioned

• Filgrastim (filgrastim)
• Interleukin-11 (interleukin-11)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Breast Cancer, Gestational Trophoblastic Tumor | Phase 2 | Status: COMPLETED